Thomas Cusack - 30 Jan 2026 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/Kathryn Lester Attorney-in-fact for Thomas Cusack
Issuer symbol
HRTX
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
03 Feb 2026, 10:00:07 UTC
Previous filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cusack Thomas Director 100 REGENCY FOREST DRIVE, SUITE 300, CARY /s/Kathryn Lester Attorney-in-fact for Thomas Cusack 03 Feb 2026 0002094824

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award $0 +53,960 $0.000000 53,960 30 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock.